Calreticulin as cancer treatment adjuvant: Combination with photodynamic therapy and photodynamic therapy-generated vaccines

Frontiers in Oncology

Volumn 5, Issue FEB, 2015, Pages

  Korbelik, Mladen ^a   Banáth, Judit ^a   Saw, Kyi Min ^a   Zhang, Wei ^a   Čiplys, Evaldas ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

antitumor immune response; calreticulin; cancer vaccine; DAMPs; photodynamic therapy

Indexed keywords

CALRETICULIN; PHOTOSENSITIZING AGENT; TALAPORFIN; TEMOPORFIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DOSE ESCALATION; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ANALYSIS; MOLECULAR CLONING; MOUSE; NEOPLASM; NONHUMAN; PHOTODYNAMIC THERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME;

EID: 84923250101     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00015     Document Type: Article

References (26)

1. Michalak M, Groenendyk J, Szabo E, Gold LI, Opas M. Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem J (2009) 417:651-66. doi: 10.1042/BJ20081847
2. Mendlovic F, Conconi M. Calreticulin: a multifaceted protein. Nat Educ (2010) 4:1. Available from: www.nature.com/scitable/topicpage/calreticulin-a-multifaceted-protein-14237270
3. Martins I, Kepp O, Galluzzi L, Senovilla L, Schlemmer F, Adjemian S, et al. Surface-exposed calreticulin in the interaction between dying cells and phagocytosis. Ann N Y Acad Sci (2010) 1209:77-82. doi:10.1111/j.1749-6632.2010.05740.x
4. Goicoechea SM, Murphy-Ullrich JE. Cell surface calreticulin: role in signaling thrombospondin anti-adhesive activity. Madam Curie Bioscience Database. Austin, TX: Landes Bioscience (2014). Availabe at: http://www.ncbi.nlm.nih.gov/books/NBK6333/
5. Garg AD, Martin S, Golab J, Agostinis P. Danger signaling during cancer cell death: origins, plasticity and regulation. Cell Death Differ (2014) 21:26-38. doi:10.1038/cdd.2013.48
6. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol (2007) 81:1-5. doi:10.1189/jlb.0306164
7. Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology (2014) 3:e955691. doi:10.4161/21624011.2014.955691
8. Korbelik M, Zhang W, Merchant S. Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release. Cancer Immunol Immunother (2011) 60:1431-7. doi:10.1007/s00262-011-1047-x
9. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 61:250-81. doi:10.3322/caac.20114
10. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol (1992) 55:145-57. doi:10.1111/j.1751-1097.1992.tb04222.x
11. Allison RR. Photodynamic therapy: oncologic horizons. Future Oncol (2014) 10:123-4. doi:10.2217/fon.13.176
12. Korbelik M, Banath J, Canals D, Hannun YA, Separovic D. Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposure. Int Immunopharmacol (2014) 20:359-65. doi:10.1016/j.intimp.2014.03.016
13. Korbelik M, Banath J, Zhang W, Wong F, Bielawski J, Separovic D. Ceramide and sphingosine-1-phosphate/sphingosine act as photodynamic therapy-elicited damage-associated molecular patterns: release from cells and impact on tumor-associated macrophages. J Anal Bioanal Tech (2014) S1:009. doi:10.1016/j.intimp.2014.03.016
14. Korbelik M. PDT-associated host response and its role in the therapy outcome. Lasers Surg Med (2006) 38:500-8. doi:10.1002/lsm.20337
15. St Denis TG, Aziz K, Waheed AA, Huang YY, Sharma SK, Mroz P, et al. Combination approaches to potentiate immune response after photodynamic therapy of cancer. Photochem Photobiol Sci (2011) 10:792-801. doi:10.1039/c0pp00326c
16. Khurana D, Martin EA, Kasperbauer JL, O'Malley BW Jr., Salomao DR, Chen L, et al. Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy. Head Neck (2001) 23:899-906. doi:10.1002/hed.1130
17. Ciplys E, Zitkus E, Slibinskas R. Native signal peptide of human ERp57 disulfide isomerase mediates secretion of active native recombinant ER57 protein in yeast Saccharomyces cerevisiae. Protein Expr Purif (2013) 89:131-5. doi:10.1016/j.pep.2013.03.003
18. Ciplys E, Aucynaite A, Slibinskas R. Generation of human ER chaperone BiP in yeast Saccharomyces cerevisiae. Microb Cell Fact (2014) 13:22. doi:10.1186/1475-2859-13-22
19. Korbelik M. Photodynamic therapy-generated vaccines. Methods Mol Biol (2010) 635:147-53. doi:10.1007/978-1-60761-697-9_11
20. Korbelik M, Merchant S. Photodynamic therapy-generated cancer vaccine elicits acute phase and hormonal response in treated mice. Cancer Immunol Immunother (2012) 61:1387-94. doi:10.1007/s00262-012-1206-8
21. Korbelik M, Cecic I, Merchant S, Sun J. Acute phase response induction by cancer treatment with photodynamic therapy. Int J Cancer (2008) 122:1411-7. doi:10.1002/ijc.23248
22. Obeid M, Tesniere A, Ghiringhelli F, Firmia GM, Apetoh L, Perfettini J-L, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med (2007) 13:54-61. doi:10.1038/nm1523
23. Korbelik M, Sun J, Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res (2005) 65:1018-26.
24. Merchant S, Sun J, Korbelik M. Heat shock protein 70 is acute phase reactant: response elicited by tumor photodynamic therapy. Cell Stress Chaperones (2011) 16:153-62. doi:10.1007/s12192-010-0227-5
25. Basu S, Binder RJ, Ramalingam T, Srivastava PK. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity (2001) 14:303-13. doi:10.1016/S1074-7613(01)00111-X
26. Takayama S, Reed JC, Homma S. Heat shock proteins as regulators of apoptosis. Oncogene (2003) 22:9041-7. doi:10.1038/sj.onc.1207114